BridgeMD
New treatment option for Breast Cancer
Official title Biennial CEM in Women With a Personal History of Breast Cancer
ClinicalTrials.gov ID: NCT06105749
What this study is testing
- What it's testing
- This is a prospective clinical trial that will examine if biennial contrast-enhanced mammography added to annual 3D mammography (tomosynthesis) substantially improves breast cancer detection with minimal increase in false-positives, in women with a personal history of breast cancer.
- This is a blinded study.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 30 to 79, women only. Healthy volunteers may be eligible.
You may be able to join if
- Asymptomatic women, ages 30-79, with a personal history of breast cancer who are at least one year out from any breast cancer surgery and/or...
You likely can't join if
- Women with a history of prior moderate or severe iodinated contrast reaction [only those with a prior mild reaction that can be managed by...
- Women with implant(s) in the breasts to be screened (as this creates artifacts and diagnostic performance of imaging in women with implants likely...
- Women who have had bilateral mastectomy
- Women with a history of kidney failure or estimated glomerular filtration rate (eGFR) \< 45 mL/min
- Pregnancy or lactation
- Women actively being treated for cancer of any type with chemotherapy
See the full eligibility criteria
- Asymptomatic women, ages 30-79, with a personal history of breast cancer who are at least one year out from any breast cancer surgery and/or treatment and are scheduled to have a routine annual mammogram with...
- Women with a history of prior moderate or severe iodinated contrast reaction [only those with a prior mild reaction that can be managed by pre-medication AND with and a strong desire to participate will be allowed to...
- Women with implant(s) in the breasts to be screened (as this creates artifacts and diagnostic performance of imaging in women with implants likely does not generalize to those without implants, and the sample size with...
- Women who have had bilateral mastectomy
- Women with a history of kidney failure or estimated glomerular filtration rate (eGFR) \< 45 mL/min
- Pregnancy or lactation
- Women actively being treated for cancer of any type with chemotherapy
- Having only one kidney
- Women with stage 4 metastasis to visceral areas or brain
- Women who have a screening breast MRI exam within 24 months prior to the current round of CEM.
- Women who had a CEM exam within the prior 23 months
The study team makes the final eligibility decision.
Where it's taking place
- Bethel Park, Pennsylvania, United States
- Cranberry Township, Pennsylvania, United States
- Monroeville, Pennsylvania, United States
- Pittsburgh, Pennsylvania, United States
- West Mifflin, Pennsylvania, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 30 years to 79 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Bethel Park, Pennsylvania, United States; Cranberry Township, Pennsylvania, United States; Monroeville, Pennsylvania, United States; Pittsburgh, Pennsylvania, United States; West Mifflin, Pennsylvania, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.